Daniel W. Elger
Plus aucun poste en cours
Profil
Daniel W.
Elger worked as CFO, Director & Head-Investor Relations at e-Therapeutics Plc from 2011 to 2014.
He also worked as Vice President-Marketing & Communications at Sarossa Capital Ltd.
from 2002 to 2008.
Additionally, he held positions as Program Director at Avenue Healthcare Knowledge Management Ltd., Chief Commercial Officer at Summit Therapeutics Ltd., and Chief Financial & Corporate Development Officer at Calliditas Therapeutics Suisse SA. Elger received his undergraduate and doctorate degrees from the University of Oxford.
Anciens postes connus de Daniel W. Elger
| Sociétés | Poste | Fin |
|---|---|---|
| E-THERAPEUTICS PLC | Directeur Financier/CFO | 07/04/2014 |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Public Communications Contact | - |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Avenue Healthcare Knowledge Management Ltd.
 Avenue Healthcare Knowledge Management Ltd. Miscellaneous Commercial ServicesCommercial Services Avenue Healthcare Knowledge Management Ltd. provides public relations and communication consulting services to the healthcare sector. The company was founded on September 30, 1997 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Directeur Financier/CFO | - |
Formation de Daniel W. Elger
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| E-THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Avenue Healthcare Knowledge Management Ltd.
Avenue Healthcare Knowledge Management Ltd. Miscellaneous Commercial ServicesCommercial Services Avenue Healthcare Knowledge Management Ltd. provides public relations and communication consulting services to the healthcare sector. The company was founded on September 30, 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
